Importance of high-density lipoprotein-cholesterol (HDL-C) levels to the incidence of cardiovascular disease (CVD) in the elderly

Archives of Gerontology and Geriatrics

Volumn 52, Issue 2, 2011, Pages 217-222

  de Freitas, Elizabete Viana ^a   Brandão, Andréa Araújo ^a   Pozzan, Roberto ^a   Magalhães, Maria Eliane ^a   Fonseca, Flávia ^a   Pizzi, Oswaldo ^a   Campana, Érika ^a   Brandão, Ayrton Pires ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cardiovascular disease; HDL cholesterol; Health of the elderly; LDL cholesterol

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CAROTID ARTERY DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BRAZIL; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; RISK FACTORS; SOCIOECONOMIC FACTORS;

ANGINA;

EID: 79551595786     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2010.03.022     Document Type: Article

References (41)

1. Aronow W.S. Cholesterol and coronary artery disease-do we treat low HDL cholesterol or high triglycerides?. Geriatr. Aging 2002, 5:24-26.
2. Aronow W.S., Ahn C. Correlation of serum lipids with the presence or absence of coronary disease in 1793 men and women aged ≥62 years. Am. J. Cardiol. 1994, 73:702-703.
3. Asrafian H., Lim T.K., Senior R. Carotid ultrasound imaging, an effective technique for detection early atherosclerosis-vascular screening for cardiovascular disease has come of age. J. Am. Soc. Echocardiogr. 2007, 20:1-3.
4. Bilato C., Crow M.T. Atherosclerosis and the vascular biology of aging. Aging (Milano) 1996, 8:222-224.
5. Burchfiel C., Laws A., Benfante R., Goldberg R., Hwang L., Chiu D., Rodriguez B.L., Curb J.D., Sharp D.S. Combined effects of HDL cholesterol, triglyceride, and total cholesterol concentrations on 18-year risk of atherosclerotic disease. Circulation 1995, 92:1430-1436.
6. Cardenas G.A., Lavie C.J., Milani R.V. Importance and management of low levels of high-density lipoprotein cholesterol in older adults. Part I: Role and mechanism. Geriatr. Aging 2004, 7:40-44.
7. Cardenas G.A., Lavie C.J., Milani R.V. Importance and management of low levels of high-density lipoprotein cholesterol in older adults. Part II: Screening and treatment. Geriatr. Aging 2004, 7:45-48.
8. Chaimowicz F. Epidemiologia e o envelhecimento no Brasil. Tratado de Geriatria e Gerontologia 2006, 106-129. Guanabara-Koogan, Rio de Janeiro, (in Portuguese). 2nd ed. E.V. Freitas, L. Py, F.A.X. Cançado (Eds.).
9. Cornoni-Huntley J., Ostfeld A.M., Taylor J., Wallace R.B., Blazer D., Berkman L.F., Evans D.A., Kohout F.J., Lemke J.H., Scherr P.A. Established populations for epidemiologic studies of the elderly: study design and methodology. Aging (Milano) 1993, 5:27-37.
10. Corti M.C., Guralnik J.M., Salive M., Harris T., Ferrucci L., Glynn R.J., Havlik R.J. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann. Intern. Med. 1997, 126:753-760.
11. Curb D.J., Abbott R.D., Rodriguez B.L., Masaki K.H., Chen R., Popper J.S., Petrovitch H., Ross G.W., Schatz I.J., Belleau G.C., Yano K. High density lipoprotein cholesterol and the risk of stroke in elderly men: the Honolulu Heart Program. Am. J. Epidemiol. 2004, 160:150-157.
12. Diretriz para Indicações e Utilização da Ecocardiografia na Prática Clínica Arq. Bras. Cardiol. 2004, 82(Suppl. II):1-34. (in Portuguese).
13. Fitchett D. Lipid management-Who screen? Who to treat?. Geriatr. Aging 2005, 8:21-28.
14. Freitas E.V. Atividade física na terceira idade. Tópicos Especiais em Medicina do Esporte 2003, 121-142. Atheneu, Rio de Janeiro, (in Portuguese). M.A.B. Oliveira, A.C.L. Nóbrega (Eds.).
15. Garcia-Palmieri M.R. Cardiovascular disease prevention in the elderly. Clin. Geriatr. 2001, 9:69-77.
16. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360:7-22.
17. Houterman S., Vershuren W.M., Hofman A., Witteman J.C. Serum cholesterol is a risk factor for myocardial infarction in elderly men and women: the Rotterdam Study. J. Intern. Med. 1999, 246:25-33.
18. I Diretriz Brasileira sobre Cardiologia Nuclear (Atualização) Arq. Bras. Cardiol. 2006, 86(Suppl. I):4-35.
19. IDB Brasil, 2006. (accessed 05.09.08). http://tabnet.datasus.gov.br/cgi/idb2006/matriz.htm.
20. JNC7 Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252.
21. Juva K., Rastas S., Pirttijä T. Blood pressure and survival in the very old. Geriatr. Aging 2007, 10:572-577.
22. Kannel W.B. Coronary heart disease risk factors in the elderly. Am. J. Geriatr. Cardiol. 2002, 11:101-107.
23. Libby P. Biologia vascular da aterosclerose. Tratado de Doenças Cardiovasculares 2006, 921-927. Elservier Editora Ltd. 7th ed. Braunwald (Ed.).
24. Luscher T.F., Barton M. Biology of the endothelium. Clin. Cardiol. 1997, 20(Suppl. 2):3-10.
25. Mackness M.I., Durrington P.N., Mackness B. How high-density lipoprotein protects against the effect of lipid peroxidation. Curr. Opin. Lipidol. 2000, 11:383-388.
26. McLaughlin M.A. The aging heart: state-of-the-art prevention and management of cardiac disease. Geriatrics 2001, 56:45-49.
27. NCEP (National Cholesterol Education Program), 2002. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult treatment Panel III). Final Report. Available from: http://www.nhlbi.nih.gov/.
28. Price G.M., Uauy R., Breeze E., Bulpitt C.J., Fletcher A.E. Weight, shape, and mortality risk in older persons: elevated waist-hip ratio, not high body mass index, is associated with a greater risk of mortality. Am. J. Clin. Nutr. 2006, 84:449-460.
29. Rader D.J. High-density lipoprotein cholesterol and atherosclerosis. Am. J. Cardiol. 2002, 90:62i-70i.
30. Rader D.J. Regulation of reverse cholesterol transport and clinical implications. Am. J. Cardiol. 2003, 92:42J-49J.
31. Sacco R.L., Benson R.T., Kargman D.E., Boden-Albala B., Tuck C., Lin I.-F., Cheng J.F., Paik M.C., Shea S., Berglund L. High-density lipoprotein cholesterol and ischemic stroke in the elderly (the Northern Manhattan Stroke Study). J. Am. Med. Assoc. 2001, 285:2729-2735.
32. Shepherd J., Blauw G.J., Murphy M.B., Cobbe S.M., Bollen E.L., Buckley B.M., Ford I., Jukema J.W., Hyland M., Gaw A., Lagaay A.M., Perry I.J., Macfarlane P.W., Meinders A.E., Sweeney B.J., Packard C.J., Westendorp R.G., Twomey C., Stott D.J. The design of a prospective study of pravastatin in the elderly at risk (PROSPER). PROSPER study group. PROspective study of pravastatin in the elderly at risk. Am. J. Cardiol. 1999, 84:1192-1197.
33. Tall A.R., Jiang X.-C., Luo Y., Silver D. George Lyman Duff Memorial Lecture: lipid transfer proteins, HDL metabolism, and atherogenesis. Arterioscler. Thrmb. Vasc. Biol. 2000, 20:1185-1188.
34. Terry D.F., Pencina M.J., Vasan R.S., Murabito J.M., Wolf P.A., Hayes M.K., Levy D., D'Agostino R.B., Benjamin E.J. Cardiovascular risk factors predictive for survival and morbidity-free survival in the oldest-old Framingham Heart Study participants. J. Am. Geriatr. Soc. 2005, 53:1944-1950.
35. Weverling-Rijnsburger A.W.E., Jonkers I.J.A.M., Exel E., Gussekloo J., Westen-dorp R.G.J. High-density vs. low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age. Arch. Intern. Med. 2003, 163:1549-1554.
36. WHO (World Health Organization) Global Survey on Geriatrics in the Medical Curriculum 2002, WHO, Geneva. http://www.who.ch/.
37. Williams M.A., Fleg J.L., Ades P.A., Chaitman B.R., Miller N.H., Mohiuddin S.M., Ockene I.S., Taylor C.B., Wenger N.K. Secondary prevention of coronary heart disease in the elderly (with emphasis on patients ≥75 years of age): an American Heart Association Scientific Statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac Rehabilitation and Prevention. Circulation 2002, 105:1735-1743.
38. Wilson P.W., Anderson K.M., Harris T., Kannel W.B., Castelli W.P. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J. Gerontol. 1994, 49:252-255.
39. Wilson P., D'Agostino R., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factors. Circulation 1998, 97:1837-1847.
40. Wong N.D., Ridker P.M. Thrombosis inflammation and infection. Preventive Cardiology 2000, 269-289. McGraw-Hill, New York. N.D. Wong, H.R. Black, J.M. Gardin (Eds.).
41. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., McQueen M., Budaj A., Pais P., Varigos J., Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.